Press release
Asia-Pacific Generic Drugs Market Size, Industry Trends, Share and Forecast 2020-2026
Asia-Pacific generic drugs market is estimated to grow at a CAGR of nearly 8.0% during the forecast period. A significant rise in the prevalence of chronic diseases is the major factor accelerating the demand for generic medicines in the region. As per the estimation by the World Health Organization (WHO), the number of new cancer incidences expected to be reported in china was nearly 4.6 million in 2020. Further, the National Cancer Registry Programme estimates that there will be 13.9 lakh new cancer incidences reported in India in 2020, which is expected to rise to 15.7 lakh by 2025.To Request a Sample of our Report on Asia-Pacific Generic Drugs Market: https://www.omrglobal.com/request-sample/asia-pacific-generic-drugs-market
This, in turn, is leading to increasing demand for generic drugs in these countries. Cost is the major benefit associated with the use of generic drugs. The cost of generic drugs can be up to 85% lower compared to the brand-name drug. Generic drug firms do not have to invest in high initial drug development costs which results in the low cost of these drugs compared to branded drugs. The low cost of generics is acting as a major factor accelerating market growth.
Scope of the Asia-Pacific Generic Drugs Market
Market Coverage
· Market number available for 2019-2026
· Base year- 2019
· Forecast period- 2020-2026
· Segment Covered- By Application and Route of Administration
· Regions Covered- China, India, Japan, and Rest of Asia-Pacific
· Competitive Landscape- Mylan N.V., Teva Pharmaceutical Industries Ltd., Lupin Ltd., Aurobindo Pharma Ltd., and Sun Pharmaceutical Industries Ltd.
Recent Strategic Initiatives in the Asia-Pacific Generic Drugs Market
· In July 2020, Cipla declared the launch of its generic version of antiviral drug remdesivir, Cipremi, at $53.3 per 100 mg vial. This makes it among the lowest cost versions for COVID-19 treatment and Cipla is looking to deliver more than 80,000 vials within the first month.
· In July 2020, Mylan launched a generic version of Remdesivir drug, Desrem, in India for treatment of COVID-19 patients. This drug will be available at a price of nearly $64.2 per 100 mg vial as against Hetero’s Covifor at nearly 72.2 per 100 mg vial and Cipla’s Cipremi costing nearly $53.3 per 100 mg vial.
(Get 15% Discount on Buying this Report)
A full Report of Asia-Pacific Generic Drugs Market is Available at: https://www.omrglobal.com/industry-reports/asia-pacific-generic-drugs-market
Asia-Pacific Generic Drugs Market-Segmentation
By Application
· Cancer
· CVD
· Musculoskeletal Diseases
· Infectious Diseases
· Neurology
· Diabetes
· Others
By Route of Administration
· Oral
· Topical
· Injectable
· Inhaler
Asia-Pacific Generic Drugs Market– Segment by Country
· China
· Japan
· India
Rest of Asia-Pacific
Company Profiles
· Abbott Laboratories
· Aurobindo Pharma Ltd.
· Cipla Ltd.
· Dr. Reddy's Laboratories Ltd.
· Eli Lilly and Co.
· GlaxoSmithKline plc
· Glenmark Pharmaceuticals Ltd.
· Lupin Ltd.
· Merck & Co., Inc.
· Mylan N.V.
· Novartis International AG
· Novo Nordisk A/S
· Sun Pharmaceutical Industries Ltd.
· Teva Pharmaceutical Industries Ltd.
Reasons to buy from us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/asia-pacific-generic-drugs-market
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Asia-Pacific Generic Drugs Market Size, Industry Trends, Share and Forecast 2020-2026 here
News-ID: 2441685 • Views: …
More Releases from Orion Market Research Pvt Ltd
Insulated Tools Market 2023 Driving Factors Forecast Research 2029
The global insulated tools market is anticipated to grow at a considerable CAGR of 8.3% during the forecast period. One of the core factors that is fueling the market is the growing applications of electricity, and batteries in products such as toys, vehicles, homes, commercial, and others which has increased the demand for insulated tools across the globe. As per the annual report of Havells 2021, the company launched 12…
Canada Bio Succinic Acid Market Size, Share, Analysis, Industry Report and Forec …
The Canada bio succinic acid market is estimated to grow at a significant growth rate of 18.0% over the forecast period from $55.0 million in 2018. Canada is another major economy in North America and is the 2nd largest economy in the region. Due to the growing chemical, pharmaceutical, polybutylene succinate (PBS) and food packaging industry, demand for bio-succinic acid and other plastics has increased Canada’s share substantially. Bio-succinic acid…
Global Intelligent Airways Transportation System Market Size, Share, Analysis, I …
The global intelligent airways transportation system market is anticipated to grow at a significant CAGR during the forecast period. The Intelligent Airways Transportation System (IATS) enables airlines to better manage aviation operations through the use of information technology (IT). The primary purpose of Intelligent Airways Transportation System technology is to give passengers a pleasant flying experience and also ensure their safety.
Due to Covid-19, many governments instituted temporary quarantines. This had…
Global Environmental Health Safety Market Size, Share and Forecast 2021-2027
The global environmental health safety market is expected to grow at a significant CAGR during the forecast period. Environment, Health, and Safety (EHS) are used by businesses to describe laws, rules, regulations, professional programs, and workplace activities aimed at protecting employees, the public, and the environment's health and safety from workplace risks. The Environmental Health Safety department of the firm assurances that the company's work does not harm the environment…
More Releases for Generic
Prominent Generic Oncology Drugs Market Trend for 2025: Novel Formulations Trans …
Which drivers are expected to have the greatest impact on the over the generic oncology drugs market's growth?
The upward trend in cancer incidence is predicted to fuel the expansion of the generic oncology drugs market. Cancer, characterized by unregulated cell proliferation affecting numerous organs, results in considerable morbidity and mortality globally. The provision of affordable generic oncology drugs is an instrumental factor in cancer care, expanding access to vital treatments,…
Generic Theater Presents Flyin' West
NORFOLK, VA (August 2023) - Generic Theater inaugurates its 43rd season with Flyin' West, written by award-winning playwright and New York Times bestselling author Pearl Cleage. Terrance Afer-Anderson directs this production, running weekends September 8th - October 1st at Generic Theater, Norfolk's underground theater located in the basement of Chrysler Hall.
Following the end of the Civil War, many former slaves took advantage of The Homestead Act and went West to…
Generic Injectables Market growth is attributed to the increasing demand for Onc …
According to Precision Business Insights (PBI), the latest report, the generic injectables market will be worth USD 22.0 billion in 2022, growing at an 11.0% CAGR from 2022 to 2028. The global generic injectables market is segmented into the following types: Product Type (Monoclonal Antibodies, Cytokines, Insulin, Peptide Hormones, Blood Factors, Immunoglobulins, Peptide Antibiotics, Vaccines, and Others), Indication (Diabetes, Cancer, Cardiovascular Diseases, Musculoskeletal, CNS, Infections, and Others), Distribution Channel (Hospital…
A Demand On Generic Drugs Market And The Need To Push The Market Of Generic Drug …
Global Generic Drugs Market
A generic drug is pharmaceutical drug, which is bio-equivalent to a branded drug in all forms such as route of administration, strength, dosage, quality, intended use and performance. Generic drugs are usually approved after patent expiration of patent drugs. Generic drugs are safe, effective and FDA approved. The global market is filled with 44% of generic drugs.
The global generic drugs market is driven by the rise of…
Generic Drug Market: Global Generic Drug Share to Reach USD 380.60 Billion by 20 …
Zion Market Research has published a new report titled “Generic Drug Market by Brand (Pure Generic and Branded Generic) for Central Nervous System (CNS), Cardiovascular, Dermatology, Oncology, Respiratory and Others Therapeutic Applications - Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021”. According to the report, the global generic drug market accounted for around USD 200.20 billion in 2015 and is expected to reach approximately USD 380.60 billion by…
Generic Drugs: Global Collaboration Opportunities
Collaboration is the key to growth
With the recent economic turmoil affecting many markets around the world, the generic and branded sectors face similar problems.
At one time the generic sector was seen as a valuable way to bring effective products to a wider audience. This, allied to the rising cost of new advanced branded products, led to rapid expansion of the generics sector. Even markets traditionally based in the provision of…
